Skip to main navigation Skip to search Skip to main content

RVT-1401 - A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-1401 in Myasthenia Gravis Patients

Project: Research

Project Details

StatusFinished
Effective start/end date10/17/19 → 12/31/22

Funding

  • Immunovant Incorporated: $31,290.00